Hosted on MSN1h
Summit Therapeutics’ Retail Chatter Explodes As Pfizer Trial Pact Drowns Out Q4 LetdownSummit Therapeutics, Inc. shares rebounded in after-hours trading on Monday after a 14% selloff during regular hours, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback